R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds - Hallo World !!! News Today in World, In this article you read by title R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds, We've prepared this article well so you can read and retrieve information on it. Hopefully the contents of the post
Article Salisbury News, What we write can you understand. Okay, happy reading.
Title : R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
link : R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
You are now reading the article R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds With link address https://newstoday-ok.blogspot.com/2017/09/r-costs-for-cancer-drugs-are-likely.html
Title : R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
link : R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
news-today.world | Cancer drugs cost far less to develop than industry-backed research asserts, an analysis published Monday asserts. Research and development costs are a major reason that drug companies justify high prices, so this dispute has a direct bearing on the cost of medical care.
The analysis, published in the current issue of JAMA Internal Medicine, concludes that it costs, on average, $650 million to develop a new cancer drug. The authors add in another $100 million or so to account for income those companies could have had if that money had been invested in the stock market instead of in new products.
That total is far lower than the $2.7 billion figure that the drug industry frequently points to when it justifies the soaring cost of medicine. (It's far higher than $320 million — an inflation-adjusted figure from a 2001 study by the consumer group Public Citizen).
More
The analysis, published in the current issue of JAMA Internal Medicine, concludes that it costs, on average, $650 million to develop a new cancer drug. The authors add in another $100 million or so to account for income those companies could have had if that money had been invested in the stock market instead of in new products.
That total is far lower than the $2.7 billion figure that the drug industry frequently points to when it justifies the soaring cost of medicine. (It's far higher than $320 million — an inflation-adjusted figure from a 2001 study by the consumer group Public Citizen).
More
That's an article R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
Fine for article R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds This time, hopefully can benefit for you all. Well, see you in other article postings.
You are now reading the article R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds With link address https://newstoday-ok.blogspot.com/2017/09/r-costs-for-cancer-drugs-are-likely.html